The Clinical Effect of the Inhibitor of Apopotosis Protein Livin in Melanoma

Publisher： Karger

E-ISSN： 1423-0232|82|4|197-204

ISSN： 0030-2414

Source： Oncology, Vol.82, Iss.4, 2012-03, pp. : 197-204

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Glycoprotein IIb/IIIa Inhibitor-Associated Thrombocytopenia: Clinical Predictors and Effect on Outcome

By  

Cardiology, Vol. 102, Iss. 4, 2004-10 ,pp. : 184-187

Karger

Access to resources Recommend Favorite

Serum Protein S-100 Predicts Clinical Outcome in Patients with Melanoma Treated with Adjuvant Interferon – Comparison with Tyrosinase RT-PCR

By  

Oncology, Vol. 68, Iss. 4-6, 2005-08 ,pp. : 341-349

Karger

Access to resources Recommend Favorite

Strong Anti‐tumor Effect of Monosialoganglioside Specific Monoclonal Antibody 202: A Clinical Trial in a Cancer Patient with Melanoma

By  

THE JOURNAL OF DERMATOLOGY, Vol. 16, Iss. 6, 1989-12 ,pp. : 480-486

John Wiley & Sons Inc

Access to resources Recommend Favorite

The Human G147D-Protein Phosphatase 1 Inhibitor-1 Polymorphism Is Not Associated with Altered Clinical Characteristics in Heart Failure

By  

Cardiology, Vol. 112, Iss. 3, 2008-08 ,pp. : 224-231

Karger

Access to resources Recommend Favorite

Effect of combined treatment with rosuvastatin and protein kinase Cβ2 inhibitor on angiogenesis following myocardial infarction in diabetic rats

By  

International Journal of Molecular Medicine, Vol. 35, Iss. 3, 2015-01 ,pp. : 829-838

Spandidos Publications

Access to resources Recommend Favorite